Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Regeneus.
RELATED STOCKHEAD STORIES
90 Seconds With...
VIDEO: 90 Seconds With… Leo Lee, Regeneus
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
Health & Biotech
Tailoring medicine to our DNA could save our health system billions – let’s get personal
Health & Biotech
Tim Boreham: What’s next for stem cell play Regeneus as it waits for Japan deal
Health & Biotech
Regeneus’s world tour continues as it secures Euro patent
Health & Biotech
A quarter of us will have arthritis by 2040. These ASX biotechs are trying to help
Health & Biotech
Which of these ASX-listed stem cell stocks will make the next breakthrough?
Health & Biotech
Regeneus announces positive results from its cancer vaccine trial
Health & Biotech
Regeneus secures valuable US patent as it looks to a licensing deal
Health & Biotech
Regeneus stem cell trials show reduction in osteoarthritis knee pain
Health & Biotech
Why investors should pay attention to biotechs focused on China
News
How ASX small caps fared in Tuesday’s market turmoil
News
Midday winners and losers: ASX small caps feel the heat
Health & Biotech